Silverback Therapeutics competitorsClear all

Silverback Therapeutics's top competitors include NovoCure, Zymeworks, Neovii and Foghorn Therapeutics.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Silverback Therapeutics
Silverback Therapeutics
Silverback Therapeutics is a biotech company developing treatments for cancer, fibrosis, and infectious diseases.
NovoCure
NovoCure
NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.
Zymeworks
Zymeworks
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
Neovii
Neovii
Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
Foghorn Therapeutics
Foghorn Therapeutics
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
Founding Date
Founding Date
2016
Founding Date
2000
Founding Date
2003
Founding Date
2003
Founding Date
2016
Type
Type
Public
Type
Public
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Seattle, US HQ
Locations
Saint Helier, JE HQ
München, DE
Haifa, IL
Chiyoda City, JP
Root, CH
Malvern, US
New York, US
see more
Locations
Vancouver, CA HQ
Seattle, US
Locations
Rapperswil-Jona, CH HQ
Gräfelfing, DE
Lexington, US
Locations
Cambridge, US HQ
Cambridge, US
Employees
Employees
52
Employees
1,02331% increase
Employees
45519% increase
Employees
86
Employees
85
Valuation ($)
Valuation ($)
246.2 m
Valuation ($)
9.3 b
Valuation ($)
848.2 m
Valuation ($)
N/A
Valuation ($)
400.2 m
Twitter followers
Twitter followers
204
Twitter followers
2.1 k
Twitter followers
1.2 k
Twitter followers
N/A
Twitter followers
711
Number of tweets (last 30 days)
Number of tweets (last 30 days)
10
Number of tweets (last 30 days)
17
Number of tweets (last 30 days)
19
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
6
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
1.2
Average likes per tweet (last 30 days)
5.1
Average likes per tweet (last 30 days)
2.1
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
6.5
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
70%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
73.68%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
282114
Alexa Website Rank
297865
Alexa Website Rank
412524
Alexa Website Rank
N/A
Alexa Website Rank
194154
Employee Rating
Employee Rating
3.6
Employee Rating
4
Employee Rating
4.7
Employee Rating
N/A
Employee Rating
2.9

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$494.4m (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$430k (FY, 2020)
Net income
Net income
($24m) (FY, 2019)
Net income
$19.8m (FY, 2020)
Net income
N/A
Net income
N/A
Net income
($68.8m) (FY, 2020)

Operating

IND-Enabling Stage Products
IND-Enabling Stage Products
1 (Q3, 2020)
IND-Enabling Stage Products
N/A
IND-Enabling Stage Products
N/A
IND-Enabling Stage Products
N/A
IND-Enabling Stage Products
2 (Q2, 2020)

Funding

Total funding raised
Total funding raised
$ 211m
Total funding raised
N/A
Total funding raised
$ 125.9m
Total funding raised
N/A
Total funding raised
$ 50m
For sources of this data, please see the company profile

View company profiles

NovoCure
HQ
Saint Helier, JE
Employees
1,023↑ 31% increase

NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.

View company
Zymeworks
HQ
Vancouver, CA
Employees
455↑ 19% increase

Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.

View company
Neovii
HQ
Rapperswil-Jona, CH
Employees
86

Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.

View company
Foghorn Therapeutics
HQ
Cambridge, US
Employees
85

Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.

View company